Item no. |
TRC-C243200-1g |
Manufacturer |
Toronto Research Chemicals
|
CASRN |
33564-30-6 |
Amount |
1 g |
Quantity options |
10 g
1 g
250 mg
2 g
500 mg
5 g
|
Category |
|
Type |
Biochemicals |
Specific against |
other |
Purity |
>95% (HPLC) |
InCHI |
1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1 |
Smiles |
[Na+].CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)[O-])COC(=O)N |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Cefoxitin Sodium, Sodium (6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R,7S)- (9CI), 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R-cis)-, Betacef, Cefaxilin sodium, Cefoxitin sodium, Cefoxitin sodium salt, Cenomycin, Farmoxin, MK 306, Mefoxin, Mefoxithin, Mefoxitin, Merxin, Monosodium cefoxitin, Sodium cefoxitin |
Shipping condition |
Room temperature |
Hazard information |
Shipping Info: Not a Dangerous good | Air Forbidden: False | Controlled Products: Not Controlled | Hazardous Class: May cause allergy or asthma symptoms or breathing difficulties if inhaled | UN #: UNNODG |
Available |
|
Manufacturer - Category |
API standards; Pharmaceutical and veterinary compounds and metabolites; Pharmaceutical and veterinary compounds and metabolites; Cephalosporins; Antibacterial; Pharmaceutical toxicology |
Country of Origin |
Canada |
Shipping Temperature |
RT|Room Temperature |
Storage Conditions |
-20°C |
Molecular Weight |
449, 43 |
Shipping Info |
Not a Dangerous good |
Air Forbidden |
False |
Controlled Products |
Not Controlled |
MSDS Availability |
TRUE |
Hazardous Class |
May cause allergy or asthma symptoms or breathing difficulties if inhaled |
UN # |
UNNODG |
IUPAC |
sodium; (6R, 7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Manufacturer - Synonym |
Cefoxitin Sodium, Sodium (6R, 7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R, 7S)- (9CI), 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R-cis)-, Betacef, Cefaxilin sodium, Cefoxitin sodium, Cefoxitin sodium salt, Cenomycin, Farmoxin, MK 306, Mefoxin, Mefoxithin, Mefoxitin, Merxin, Monosodium cefoxitin, Sodium cefoxitin |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.